Serina Therapeutics Inc
(SER) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
4.72
-2.68%
After-hours Jan 06, 2025, 08:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Revenue | 142.00K | 500.00K | 3.04M | 54.00K | 1.73M | 1.40M | 1.40M | 1.67M |
Cost of Revenue | 171.00K | 145.00K | 150.00K | 1.28M | 998.50K | 841.00K | 685.00K | 911.00K |
Gross Profit | -29.00K | 355.00K | 2.89M | -1.23M | 729.50K | 555.00K | 719.00K | 755.00K |
Operating Income | -9.96M | -2.27M | -1.63M | -10.41M | -12.56M | -10.45M | -8.42M | -12.74M |
Interest Income | n/a | 1.76K | 10.86K | n/a | 29.00K | 116.00K | n/a | n/a |
Pretax Income | -14.81M | -2.68M | -1.26M | -10.40M | -12.24M | -7.73M | -6.64M | -17.36M |
Net Income | -14.80M | -2.68M | -1.26M | -10.87M | -12.15M | -7.50M | -6.58M | -15.49M |
Selling & General & Admin | 9.33M | 1.29M | 1.30M | 5.60M | 7.94M | 5.65M | 3.87M | 5.62M |
Research & Development | 603.00K | 1.57M | 3.80M | 3.58M | 5.35M | 5.35M | 5.27M | 7.87M |
Other Expenses | n/a | -265.92K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.93M | 2.77M | 4.67M | 9.18M | 13.29M | 11.00M | 9.14M | 13.49M |
Interest Expense | 4.90M | 15.88K | 3.09K | 404.00K | n/a | n/a | 12.00K | 25.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.10M | 2.77M | 4.67M | 10.46M | 14.29M | 11.84M | 9.82M | 14.40M |
Income Tax | -8.00K | -250.04K | 3.09K | 466.00K | 148.00K | -229.00K | -57.00K | -1.86M |
Shares Outstanding (Basic) | 1.08M | 1.08M | 1.08M | 1.07M | 1.06M | 992.72K | 1.02M | 1.02M |
Shares Outstanding (Diluted) | 1.08M | 1.08M | 1.08M | 1.07M | 1.06M | 992.72K | 1.02M | 1.02M |
EPS (Basic) | -13.72 | -2.49 | -1.17 | -10.14 | -11.47 | -7.56 | -6.46 | -15.21 |
EPS (Diluted) | -13.72 | -2.49 | -1.17 | -10.14 | -11.47 | -7.56 | -6.46 | -15.21 |
EBITDA | -9.78M | -2.60M | -1.59M | -8.74M | -11.61M | -7.20M | -7.74M | -11.89M |
Depreciation & Amortization | 131.00K | 132.00K | 131.00K | 1.25M | 951.00K | 535.00K | 682.00K | 845.00K |